Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Shuhui Wang, Iva Breskovska, Shreya Gandhy, Anna Rostedt Punga, Jeffery T. Guptill & Henry J. Kaminski. (2018) Advances in autoimmune myasthenia gravis management. Expert Review of Neurotherapeutics 18:7, pages 573-588.
Read now
Read now
Aliona Nacu, Jintana Bunpan Andersen, Vitalie Lisnic, Jone Furlund Owe & Nils Erik Gilhus. (2015) Complicating autoimmune diseases in myasthenia gravis: a review. Autoimmunity 48:6, pages 362-368.
Read now
Read now
Marc H. De Baets. (2010) Insights in the autoimmunity of myasthenia gravis. Autoimmunity 43:5-6, pages 341-343.
Read now
Read now
Kathleen Vrolix, Judith Fraussen, Peter C. Molenaar, Mario Losen, Veerle Somers, Piet Stinissen, Marc H. De Baets & Pilar Martínez-Martínez. (2010) The auto-antigen repertoire in myasthenia gravis. Autoimmunity 43:5-6, pages 380-400.
Read now
Read now
Articles from other publishers (22)
Annabel M. Ruiter, Ziqi Wang, Zhao Yin, Willemijn C. Naber, Jerrel Simons, Jurre T. Blom, Jan C. van Gemert, Jan J. G. M. Verschuuren & Martijn R. Tannemaat. (2023) Assessing facial weakness in myasthenia gravis with facial recognition software and deep learning. Annals of Clinical and Translational Neurology 10:8, pages 1314-1325.
Crossref
Crossref
Dawn Lobban, Jacqui Oliver, Kelly Davio, Kenza Seddik & Veronica Porkess. (2023) Evaluation of the quality of patient involvement in a patient-led analysis of the lived experience of a rare disease. Research Involvement and Engagement 9:1.
Crossref
Crossref
Dana L.E. Vergoossen, Annabel M. Ruiter, Kevin R. Keene, Erik H. Niks, Martijn R. Tannemaat, Ellen Strijbos, Alexander F. Lipka, Els C. Jol van der Zijde, Maarten J.D. van Tol, Jaap A. Bakker, Brigitte A. Wevers, Elisabet Westerberg, Lúcia S. Borges, Olivia C. Tong, David P. Richman, Isabel Illa, Anna Rostedt Punga, Amelia Evoli, Silvère M. van der Maarel, Jan J. Verschuuren & Maartje G. Huijbers. (2022) Enrichment of serum IgG4 in MuSK myasthenia gravis patients. Journal of Neuroimmunology 373, pages 577978.
Crossref
Crossref
Kevin R. Keene, Hermien E. Kan, Stijn van der Meeren, Berit M. Verbist, Martijn R. Tannemaat, Jan‐Willem M. Beenakker & Jan J.G.M. Verschuuren. (2022) Clinical and imaging clues to the diagnosis and follow‐up of ptosis and ophthalmoparesis. Journal of Cachexia, Sarcopenia and Muscle 13:6, pages 2820-2834.
Crossref
Crossref
Derin Marbin, Sophie K. Piper, Sophie Lehnerer, Ulrike Harms & Andreas Meisel. (2022) Mental health in myasthenia gravis patients and its impact on caregiver burden. Scientific Reports 12:1.
Crossref
Crossref
Anna Rostedt Punga, Paul Maddison, Jeannine M Heckmann, Jeffrey T Guptill & Amelia Evoli. (2022) Epidemiology, diagnostics, and biomarkers of autoimmune neuromuscular junction disorders. The Lancet Neurology 21:2, pages 176-188.
Crossref
Crossref
Annabel M. Ruiter, Ellen Strijbos, Robert H.P. de Meel, Alexander F. Lipka, Wouter F. Raadsheer, Martijn R. Tannemaat & Jan J.G.M. Verschuuren. (2021) Accuracy of patient-reported data for an online patient registry of autoimmune myasthenia gravis and Lambert-Eaton myasthenic syndrome. Neuromuscular Disorders 31:7, pages 622-632.
Crossref
Crossref
Annabel M. Ruiter, Jan J.G.M. Verschuuren & Martijn R. Tannemaat. (2021) Prevalence and associated factors of fatigue in autoimmune myasthenia gravis. Neuromuscular Disorders 31:7, pages 612-621.
Crossref
Crossref
Jiaduo Li, Guoyan Qi & Yaling Liu. (2021) Effect of Buzhong Yiqi decoction on anti-acetylcholine receptor antibody and clinical status in juvenile ocular myasthenia gravis. Medicine 100:44, pages e27688.
Crossref
Crossref
Annabel M. Ruiter, Jan J.G.M. Verschuuren & Martijn R. Tannemaat. (2020) Fatigue in patients with myasthenia gravis. A systematic review of the literature. Neuromuscular Disorders 30:8, pages 631-639.
Crossref
Crossref
Zoi Zagoriti, George Lagoumintzis, Gianluca Perroni, George Papathanasiou, Andreas Papadakis, Vincenzo Ambrogi, Tommaso Claudio Mineo, John S. Tzartos & Konstantinos Poulas. (2018) Evidence for association of STAT4 and IL12RB2 variants with Myasthenia gravis susceptibility: What is the effect on gene expression in thymus?. Journal of Neuroimmunology 319, pages 93-99.
Crossref
Crossref
Guoyan Qi, Peng Liu, Shanshan Gu, Hongxia Yang, Huimin Dong & Yinping Xue. (2018) Whole-exome sequencing reveals a rare interferon gamma receptor 1 mutation associated with myasthenia gravis. Neurological Sciences 39:4, pages 717-724.
Crossref
Crossref
Justyna Kubiszewska, Beata Szyluk, Piotr Szczudlik, Zbigniew Bartoszewicz, Małgorzata Dutkiewicz, Maksymilian Bielecki, Tomasz Bednarczuk & Anna Kostera-Pruszczyk. (2016) Prevalence and impact of autoimmune thyroid disease on myasthenia gravis course. Brain and Behavior 6:10, pages e00537.
Crossref
Crossref
Anne Taraldsen Heldal, Geir Egil Eide, Fredrik Romi, Jone Furlund Owe & Nils Erik Gilhus. (2014) Repeated Acetylcholine Receptor Antibody-Concentrations and Association to Clinical Myasthenia Gravis Development. PLoS ONE 9:12, pages e114060.
Crossref
Crossref
J. R. Parr, M. J. Andrew, M. Finnis, D. Beeson, A. Vincent & S. Jayawant. (2014) How common is childhood myasthenia? The UK incidence and prevalence of autoimmune and congenital myasthenia. Archives of Disease in Childhood 99:6, pages 539-542.
Crossref
Crossref
Paraskevi Zisimopoulou, Talma Brenner, Nikolaos Trakas & Socrates J. Tzartos. (2013) Serological diagnostics in myasthenia gravis based on novel assays and recently identified antigens. Autoimmunity Reviews 12:9, pages 924-930.
Crossref
Crossref
John H. J. Wokke, Pieter A. van Doorn, Jessica E. Hoogendijk & Marianne de Visser. 2013. Neuromuscular Disease A Case-Based Approach. Neuromuscular Disease A Case-Based Approach
107
107
.
John H. J. Wokke, Pieter A. van Doorn, Jessica E. Hoogendijk & Marianne de Visser. 2013. Neuromuscular Disease A Case-Based Approach. Neuromuscular Disease A Case-Based Approach
103
106
.
Zoi Zagoriti, Manousos E. Kambouris, George P. Patrinos, Socrates J. Tzartos & Konstantinos Poulas. (2013) Recent Advances in Genetic Predisposition of Myasthenia Gravis. BioMed Research International 2013, pages 1-12.
Crossref
Crossref
Jaap J. Plomp, Maartje G. Huijbers, Silvère M. van der Maarel & Jan J. Verschuuren. (2012) Pathogenic IgG4 subclass autoantibodies in MuSK myasthenia gravis. Annals of the New York Academy of Sciences 1275:1, pages 114-122.
Crossref
Crossref
Rinse Klooster, Jaap J. Plomp, Maartje G. Huijbers, Erik H. Niks, Kirsten R. Straasheijm, Frank J. Detmers, Pim W. Hermans, Kevin Sleijpen, Aad Verrips, Mario Losen, Pilar Martinez-Martinez, Marc H. De Baets, Silvère M. van der Maarel & Jan J. Verschuuren. (2012) Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice. Brain 135:4, pages 1081-1101.
Crossref
Crossref
Jozsef Pal, Csilla Rozsa, Samuel Komoly & Zsolt Illes. (2011) Clinical and biological heterogeneity of autoimmune myasthenia gravis. Journal of Neuroimmunology 231:1-2, pages 43-54.
Crossref
Crossref